Market revenue in 2021 | USD 788.4 million |
Market revenue in 2028 | USD 843.7 million |
Growth rate | 1% (CAGR from 2021 to 2028) |
Largest segment | Pcr-based amplification |
Fastest growing segment | Loop Mediated Isothermal Amplification (LAMP) |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | PCR-based Amplification, Loop Mediated Isothermal Amplification (LAMP), Nucleic Acid Sequence Based Amplification (NASBA), Strand Displacement Amplification (SDA), Multiple displacement amplification (MDA), Rolling Circle Amplification (RCA), Ramification amplification method (RAM) |
Key market players worldwide | Qiagen NV, Illumina Inc, Bio-Rad Laboratories Inc, Silicon Laboratories Inc, Merck KGaA, Promega, Takara Bio Inc, Danaher Corp, New England Biolabs, 4Basebio, LGC Group, Vazyme Biotech, MyBiosource |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gene amplification technologies market will help companies and investors design strategic landscapes.
Pcr-based amplification was the largest segment with a revenue share of 90.64% in 2021. Horizon Databook has segmented the Italy gene amplification technologies market based on pcr-based amplification, loop mediated isothermal amplification (lamp), nucleic acid sequence based amplification (nasba), strand displacement amplification (sda), multiple displacement amplification (mda), rolling circle amplification (rca), ramification amplification method (ram) covering the revenue growth of each sub-segment from 2018 to 2028.
Italy is one of the significant contributors to Europe's revenue generation. As Italy was one of the worst hit countries in the European region due to the SARS-CoV-2 pandemic, the production of PCR based test kits has witnessed growth in the last few months.
This is expected to positively impact the market growth of gene amplification technologies in the country. In June 2020, a group of Italian researchers used whole-genome sequencing for the identification of the multiple genetic variants that are important in determining COVID-19 disease susceptibility.
The on-going study called GEN-COVID involves 35 hospitals across the country. Such projects are anticipated to increase the use of gene amplification technologies in the country thus leading to market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy gene amplification technologies market , including forecasts for subscribers. This country databook contains high-level insights into Italy gene amplification technologies market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account